Cellectar Biosciences, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Cellectar Biosciences, Inc. (CLRB) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -12.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-03-13
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -12.10%.
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -9.95%.
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -5.92%, a 156.33% decline from fiscal 2021.
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was 10.51%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -12.10% 10-K · filed 2025-03-13 | |
| 2023-12-31 | -9.95% 10-K · filed 2025-03-13 | -11.50% 10-K · filed 2024-03-27 |
| 2022-12-31 | -5.92% 10-K/A · filed 2024-10-29 | 6.57% 10-K · filed 2023-03-09 |
| 2021-12-31 | 10.51% 10-K · filed 2023-03-09 | -10.51% 10-K · filed 2022-03-21 |
| 2020-12-31 | -6.13% 10-K · filed 2022-03-21 | |
| 2019-12-31 | -5.21% 10-K · filed 2021-03-02 | |
| 2018-12-31 | -3.44% 10-K · filed 2020-03-09 | |
| 2017-12-31 | 8.43% 10-K · filed 2019-02-26 | |
| 2016-12-31 | 9.55% 10-K · filed 2018-03-21 | |
| 2015-12-31 | 3.07% 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |